Exports In 2022, Canada exported $884M in Vaccines, blood, antisera, toxins and cultures, making it the 23rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 106th most exported product in Canada. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Canada are: United States ($519M), Norway ($57M), Belgium ($42.6M), France ($33.4M), and South Korea ($21.5M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Canada between 2021 and 2022 were Dominican Republic ($19.6M), Italy ($10.5M), and United States ($10.1M).
Imports In 2022, Canada imported $7.71B in Vaccines, blood, antisera, toxins and cultures, becoming the 12th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 9th most imported product in Canada. Canada imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($3.24B), Switzerland ($1.47B), Germany ($646M), Belgium ($578M), and Ireland ($547M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Canada between 2021 and 2022 were South Korea ($75.4M), Singapore ($52.3M), and Sweden ($48.3M).